Skip to main navigation Skip to search Skip to main content

Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results.

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalJournal of Lipid Research
StatePublished - 2016.04.30

Cite this